English Extended Distribution Financial Content iCN Internal Distribution PR-Wirein Press Release Reportedtimes Research Newswire

Global Home DNA Test Kit Market Opportunity Exceeds USD 10 Billion

Global Information, Inc. [JASDAQ 4171]

In last few decades, the field of genetics has witnessed rapid evolution which has eventually led to the development of genetic tests. In recent times, home genetic testing kits have entered the market which can be done at home without the prescription of healthcare professional. The introduction of home genetic testing kit has empowered people and gave them a feeling of personal control in improving the quality of their lives. It allows the rapid diagnosis of disorders when public or other private healthcare resources are in short supply. Till date, several home genetic testing kits have entered the global market which provides insights on various things including genetic disease risk analysis, personal wellbeing, ancestry, diet, nutrition, parenting, and others.

One of the early players in home genetic testing kit market is 23andMe which has been known for its at-home DNA testing kit that only requires customers to mail in a little tube of saliva in order to gain useful insight into their genetic predispositions. Other private companies that are pushing the innovation edge and warrant watching include companies like Forward, which is a subscription-based service that combines DNA sequencing, AI, full-body scanning, and wearable’s for mobile health monitoring along with instant access to medical care via smartphone app. The other key players in the market include Everlywell, Ancestry, MapmyGenome, EasyDNA, MedGenome, DNAwise, DNA labs, Genes2me, and others.

Further, the arrival of COVID-19 pandemic has also pushed the home test kits market during the past two years. The rising COVID-19 cases globally have encouraged several pharmaceutical companies to develop cost-effective and easily available kit for diagnosis of the virus. In November 2020, Lucira COVID-19 All-In-One Test Kit was the first COVID-19 diagnostic kit for self-testing at home and that provides rapid results. More recently in October 2021, FDA issued EUA for the Acon Laboratories Flowflex COVID-19 home test, which is an over-the-counter antigen test.

Continue reading: https://www.giiresearch.com/report/kui1066913-home-dna-test-kit-market-opportunity-forecast.html 

Contact: marketing@giiresearch.com 

 

Tags: Chronic Disease Testing Market, 23andMe, home testing research, US home generic testing market

See Campaign: https://www.giiresearch.com/report/kui1066913-home-dna-test-kit-market-opportunity-forecast.html

Contact Information:

Global Information, Inc. [JASDAQ 4171] https://www.giiresearch.com/ Toll Free (US): +1-866-353-3335 Outside US: +1-860-674-8796 Europe (Belgium): +32-2-535-7543 Email: marketing@giiresearch.com

Tags:
Reportedtimes, Financial Content, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English

Contact Information:

Global Information, Inc. [JASDAQ 4171]
https://www.giiresearch.com/
Toll Free (US): +1-866-353-3335
Outside US: +1-860-674-8796
Europe (Belgium): +32-2-535-7543
Email: marketing@giiresearch.com